首页 工具
登录
购物车
Ertiprotafib

Ertiprotafib

产品编号 T15243   CAS 251303-04-5
别名: PTP 112

Ertiprotafib is a PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist inhibitor ( IC50s: 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ).

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Ertiprotafib Chemical Structure
Ertiprotafib, CAS 251303-04-5
规格 价格/CNY 货期 数量
2 mg ¥ 2,570 5日内发货
25 mg ¥ 10,600 6-8周
50 mg ¥ 13,800 6-8周
100 mg ¥ 17,500 6-8周
产品目录号及名称: Ertiprotafib (T15243)
点击图片重新获取验证码
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Ertiprotafib is a PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist inhibitor ( IC50s: 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ).
靶点活性 PTP1B:1.6 μM, PPARβ:~1 μM (EC50), PPARα:~1 μM (EC50), IKKβ:400 nM
体外活性 Ertiprotafib is a potent IKK-β inhibitor (IC50: 400 nM), which is much lower than that required for the half-maximal inhibition of the p-nitrophenyl phosphatase activity of PTP1B. Ertiprotafib is at least a dual PPARα and PPARβ agonist with EC50 values for transactivation of 1 μM. The reported IC50 value of Ertiprotafib against PTP1B ranges from 1.6 to 29 μM depending on the assay conditions [2]. Such activities readily explain the observations with suprapharmacologic doses of these [1].
体内活性 As seen with the treatment of ob/ob mice, both Ertiprotafib and compound 3 seem to obviously improve glucose metabolism in rats. Both Ertiprotafib and compound 3 increase in glucose disposal after an oral challenge. It is noteworthy that lipid levels are also reduced in treated animals. At 25 mg/kg/day, these compounds reduce both fasting blood glucose and insulin levels compared with vehicle-treated rats. Both triglyceride and free fatty acid levels are substantially reduced in rats treated with 25 mg/kg/day of either compound. Decreased lipid levels may be unexpected for a pure PTP1b inhibitor. As mentioned above, that rats treated with suprapharmacologic doses of Ertiprotafib display signs of PPAR family activation [2].
别名 PTP 112
分子量 559.51
分子式 C31H27BrO3S
CAS No. 251303-04-5

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

参考文献

1. Shrestha S, et al. PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta). Bioorg Med Chem Lett. 2007 May 15;17(10):2728-30. Epub 2007 Mar 3. 2. Erbe DV, et al. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol Pharmacol. 2005 Jan;67(1):69-77.
Kudinoside D XMD16-5 BAY-0069 Gentianine SP4e SP4f Lanifibranor Arhalofenate

剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Ertiprotafib 251303-04-5 DNA Damage/DNA Repair Metabolism Phosphatase PPAR PTP-112 PTP 112 PTP112 Inhibitor inhibitor inhibit

 

陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼